Corrigendum to "Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients"

J Immunol Res. 2022 Jan 25:2022:7931597. doi: 10.1155/2022/7931597. eCollection 2022.

Authors

Affiliations

¹ Laboratory of Cellular Immunity, Institute of Clinical Immunology, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, China.
² The Pennington School, 112 W Delaware Ave, Pennington, NJ 08534, USA.
³ Department of Hepatopathy, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Abstract

[This corrects the article DOI: 10.1155/2019/8983903.].

Copyright © 2022 Long-Shan Ji et al.

Publication types

Published Erratum